These studies raise the prospect that many effects of the BDNF polymorphism in ‘healthy’ older cohorts, as described above, may have been influenced by the presence of sub-clinical AD and other neurodegenerative pathology. The gene discussed is BDNF; the disease is Alzheimer disease.